Compare, Analyse Sanofi India with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs6,840380-   
Low Rs4,630274-   
Sales per share (Unadj.) Rs1,203.1113.0-  
Earnings per share (Unadj.) Rs165.3-28.5-  
Cash flow per share (Unadj.) Rs209.9-23.6-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.688.7-  
Shares outstanding (eoy) m23.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.9 164.7%   
Avg P/E ratio x34.7-11.5 -302.2%  
P/CF ratio (eoy) x27.3-13.9 -197.2%  
Price / Book Value ratio x6.03.7 161.5%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,07855,187 239.3%   
No. of employees `0003.34.3 76.9%   
Total wages/salary Rs m4,0683,464 117.4%   
Avg. sales/employee Rs Th8,393.84,443.0 188.9%   
Avg. wages/employee Rs Th1,232.4806.8 152.7%   
Avg. net profit/employee Rs Th1,153.0-1,119.5 -103.0%   
INCOME DATA
Net Sales Rs m27,70819,074 145.3%  
Other income Rs m897134 671.6%   
Total revenues Rs m28,60519,207 148.9%   
Gross profit Rs m6,235-3,305 -188.6%  
Depreciation Rs m1,027823 124.8%   
Interest Rs m7517 1.4%   
Profit before tax Rs m6,098-4,512 -135.2%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292282 813.0%   
Profit after tax Rs m3,806-4,806 -79.2%  
Gross profit margin %22.5-17.3 -129.9%  
Effective tax rate %37.6-6.2 -601.5%   
Net profit margin %13.7-25.2 -54.5%  
BALANCE SHEET DATA
Current assets Rs m15,92213,970 114.0%   
Current liabilities Rs m6,2357,860 79.3%   
Net working cap to sales %35.032.0 109.1%  
Current ratio x2.61.8 143.7%  
Inventory Days Days64111 57.4%  
Debtors Days Days21124 16.8%  
Net fixed assets Rs m7,5398,143 92.6%   
Share capital Rs m23089 259.7%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,19214,971 148.2%   
Long term debt Rs m05,261 0.0%   
Total assets Rs m29,83928,281 105.5%  
Interest coverage x872.1-7.7 -11,279.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 137.7%   
Return on assets %12.8-15.2 -84.3%  
Return on equity %17.2-32.1 -53.4%  
Return on capital %27.5-19.8 -138.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,7391,628 229.7%  
From Investments Rs m-731-500 146.2%  
From Financial Activity Rs m-1,9724,775 -41.3%  
Net Cashflow Rs m1,0365,903 17.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.24 Rs / ZAR

Compare SANOFI INDIA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: WOCKHARDT  SHASUN PHARMA  NEULAND LABS  TORRENT PHARMA  ALKEM LABORATORIES  



Today's Market

SGX Nifty Trades Flat, Interglobe Aviation QIP, Rising Premium for Non-Life Insurers, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended lower yesterday. Benchmark indices ended nearly 1% lower, tracking weakness in global markets and dragged primarily by finance and banking stocks.

Related Views On News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SANOFI INDIA SHARE PRICE


May 12, 2021 09:33 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS